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Abstract
Background: The interface between research and policymaking in low-income countries is highly
complex. The ability of health systems research to influence policy processes in such settings face
numerous challenges. Successful analysis of the research-policy interface in these settings requires
understanding of contextual factors as well as key influences on the interface. Future Health Systems
(FHS): Innovations for Equity is a consortium conducting research in six countries in Asia and Africa.
One of the three cross-country research themes of the consortium is analysis of the relationship
between research (evidence) and policy making, especially their impact on the poor; insights gained
in the initial conceptual phase of FHS activities can inform the global knowledge pool on this subject.
Discussion: This paper provides a review of the research-policy interface in low-income countries
and proposes a conceptual framework, followed by directions for empirical approaches. First, four
developmental perspectives are considered: social institutional factors; virtual versus grassroots
realities; science-society relationships; and construction of social arrangements. Building on these
developmental perspectives three research-policy interface entry points are identified: 1.
Recognizing policy as complex processes; 2. Engaging key stakeholders: decision-makers, providers,
scientists, and communities; and 3. Enhancing accountability. A conceptual framework with three
entry points to the research-policy interface – policy processes; stakeholder interests, values, and
power; and accountability – within a context provided by four developmental perspectives is
proposed. Potential empirical approaches to the research-policy interface are then reviewed.
Finally, the value of such innovative empirical analysis is considered.
Conclusion: The purpose of this paper is to provide the background, conceptual framework, and
key research directions for empirical activities focused on the research-policy interface in low
income settings. The interface can be strengthened through such analysis leading to potential
improvements in population health in low-income settings. Health system development cognizant
of the myriad factors at the research-policy interface can form the basis for innovative future health
systems.
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Background
The interface between policymaking and research in low-
income countries is highly complex. Health systems
research in such settings face a number of challenges
including under-investment, lack of human capacity, lack
of public demand, inadequate utilization, and poor dis-
semination of results [1-3]. Mismatch between need for
health research and investment has been highlighted and
attempts made to address the '10/90' gap including:
research capacity strengthening; promotion of research
investment; and the establishment of global and national
health forums [4,5]. In addition, empirical work on map-
ping health resource flows and health research systems
has progressed [6,7]. At the same time, the search for strat-
egies to "get research findings into policy and practice"
has gained momentum and the global literature has called
for further exploration in the area of research to policy [8].
In particular, engaging decision makers in specific areas of
health research, and promoting the use of surveys of deci-
sion makers has been advocated [9].
The developed world is the focus of much of the explora-
tion in the arena of research to policy [10,11] and specifi-
cally on pathways from research to development of
clinical guidelines, or on the use of systematic reviews
[12]. A summary of the key challenges to bridging the
research-policy gap and strategies to overcome them in
the developed world exist [13]. In recent years, some
country specific analyses of the research-policy interface
in the developing world have also been articulated. These
include analyses from: India [14]; Lao PDR [15]; Cambo-
dia [16]; Viet Nam [17]; Thailand [18]; Bangladesh [19];
Nepal [20]; Sri Lanka [21]; Uganda [22]; Kenya [23];
Nigeria [24]; Mali [25]; and Mexico [26]. These analyses
either focus on health policy making in general, or focus
on specific but divergent health issues and the policies
that pertain to them.
Despite the relative paucity of empirical work, the World
Health Organization [27], the Alliance for Health Policy &
Systems Research [28], the Council on Health Research
for Development [29], and other organizations have
made important contributions to the knowledge base on
the research to policy interface [3,6,30]. These contribu-
tions are: reliant on the use of small scale, case study
approaches; focused on a few health issues; limited to one
country or to specific locations within a country; and
largely unpublished in the peer-reviewed literature,
although important reports and documents have been
produced and circulated. The Alliance for Health Policy
and Systems Research has produced such a publication,
which presents the common conceptual model of a linear
process – evidence is generated, findings are made availa-
ble, and eventually decisions are influenced [31]. In real-
ity the process of evidence translation into decision
making within government or other institutions is rather
more complex.
Drawing on work on policy processes in other arenas,
research and the evidence it generates can be seen differ-
ently. Evidence is not the rational, objective, set of facts it
is sometimes made out to be; rather it can be seen as forms
of knowledge – partial perspectives – forwarded by particu-
lar people and institutions, and sometimes contested by
others [32,33]. Knowledge relevant to health system
organization is not just about diseases and technologies
(e.g. disease epidemiology, drug or vaccine efficacy), or
about nature-society interactions (e.g. social influences on
disease pathways). Crucially, the importance of knowl-
edge about society and social institutions, which differs
from knowledge about diseases or nature-society interac-
tions, cannot be ignored. More importantly, understand-
ing which knowledge and perspectives come to influence
policy, and which are excluded, requires understanding
the policy process as non-linear – shaped through politi-
cized negotiations amongst multiple actors [32,34-36].
Furthermore, there is often a process of mutual construc-
tion of research and policy, in which policy negotiations
shape what kinds of research are funded and carried out,
and which are not.
The Research Programme Consortium (RPC), Future
Health Systems: Innovations for Equity, funded by the
Department for International Development (DFID),
United Kingdom hopes to heed the calls made by previ-
ous work done in this field, and contribute to both meth-
ods and results that are useful for understanding the nexus
of research and policy and how that can positively impact
the poor [37,38]. The overall goal of the 'research to pol-
icy' thematic activities in the consortium is to understand
the relationship between research (evidence) and the
development of policies, especially their impact on the
poor. More specifically this consortium seeks to: docu-
ment previous experiences of decision makers with health
research; understand overall values  placed on health
research and evidence by decision makers; define the con-
text and conditions under which decision makers will
demand health research; identify characteristics of health
research that make it attractive to decision makers; and
explore the existence and performance of institutional
mechanisms that allow interaction between research evi-
dence and policy development and implementation at
national and sub-national level.
Given the above overarching and specific thematic goals,
this paper aims to provide the background, conceptual
framework, and key research directions for such types of
empirical activities in low income settings. Firstly, four
key developmental perspectives that are particularly rele-
vant contextual factors to the research-policy interface areBMC Public Health 2007, 7:309 http://www.biomedcentral.com/1471-2458/7/309
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considered. Second, three entry points for the research-
policy interface in the developing world are discussed.
Third, a conceptual framework for use in the analysis of
the research-policy interface is proposed. Fourth, poten-
tial study designs and methodologies required in
responding to the identified knowledge gaps in the
research-policy interface in low-income countries are
identified. Finally, the overall added value of the entire
approach is considered.
Discussion
The context of health decisions
Analysis of policy processes involves understanding not
only the mechanics of decision-making and implementa-
tion, but also more complex underlying practices of policy
framing. Framing here refers to how boundaries are drawn
around problems, how policy problems are defined, and
what is included and excluded. Problems and solutions
related to health systems may include disease problems
and proposed solutions in health interventions. However,
problems and solutions related to health systems also
encompass broader questions about health system organ-
ization, and new forms of social, political or economic
arrangements. Understanding and addressing these
broader dynamics, necessary if health systems are to
respond to the poor, may be more important than fine-
tuning the performance of particular institutional
arrangements. Four key developmental perspectives
which form an essential part of these broader dynamics
are explored below.
Social institutional factors
Health systems are complex institutions embedded in
rules-based institutional arrangements, but also sustained
through social norms and informal practices [39]. Atti-
tudes and understanding of workers in these institutions
and those who use them – their framing of problems and
solutions – influence performance. Much evidence on the
impact of alternative forms of health sector organization
comes from advanced market economies, where institu-
tional arrangements and behavioral norms are relatively
stable [40]. Health system researchers in these countries
have constructed a body of knowledge enabling them to
predict the performance of various institutional arrange-
ments.
The situation is different in many low-income countries,
where institutions are partially functional and "rules of
the game" are changing rapidly [41]. Institutions of the
labor market, regulation of professionals and pharmaceu-
ticals, local accountability mechanisms, and the role of
the legal system are all in the process of development.
Interventions may perform very differently in this context
than in mature market economies. Furthermore, expecta-
tions and understanding of social system operation vary
considerably between stakeholders. These stakeholders,
who include citizens, organization managers, and social
theorists, are all participating in the creation of new social
arrangements; the behavioral norms and expectations of
these arrangements are currently being shaped [42]. The
language to understand and describe them is also under
formation. See Table 1 for key points when considering
social institutional factors.
Virtual versus grassroots realities
Marked differences exist between official discourse about
health systems and the operational reality in many low-
income countries, where a significant proportion of activ-
ities take place outside formal rules of national legal
frameworks [43]. In the health sector, informal payments
and mechanisms to create and preserve reputations and
support households facing major medical bills play a very
important role. There is little systematic understanding of
how these systems work and "policies" take little account
of them [39]. There is also little understanding of how dif-
ferent stakeholders envisage their future and how they
engage with the politics of health system construction.
Influencing agents such as opinion leaders also affect the
disconnection between formal rules and reality of deci-
sion making. The means through which these influencing
agents act vary depending on the type of opinion leader.
Thus different types of opinion leaders influence health
providers than those that influence household behavior;
both are however critical to adoption of knowledge in
decision-making and policy implementation.
Many low-income countries receive a proportion of their
budgets for health systems from a variety of donor agen-
cies. These agencies play an important role in influencing
government systems and in determining the dominant
discourse for discussing systems development [44,45].
Reform options are often negotiated between officials in
government and donor agencies, while other important
stakeholders do not fully participate in these processes.
See Table 2 for key points when considering virtual versus
grassroots realities.
Table 1: Social institutional factors – key points
1. Health systems are complex organizations embedded in rules and social norms
2. Human factors within institutions influence processes
3. Rapid change in institutions in low-income countries affect processes
4. Expectations of institutions vary between stakeholdersBMC Public Health 2007, 7:309 http://www.biomedcentral.com/1471-2458/7/309
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Science and society
Much literature exists on the translation of evidence on
scientific phenomena into technological changes that
influence work and consumption. The history of the
knowledge economy points to the close inter-relationship
between the growth of basic scientific knowledge, the con-
struction of institutional arrangements to legitimate this
knowledge, and a society's capacity to transform techno-
logical developments into the creation of a modern econ-
omy [46]. The process refers to the existence of a
community of educated people, who develop shared
understanding of scientific explanations of nature, ena-
bling them to accept technological innovations and fit
them into a systematic narrative. This process is under-
pinned by creation of institutions to support trusted scien-
tific discourse [46].
Nevertheless even in advanced market economies diverse
discourses exist surrounding scientific and technical phe-
nomena [47]. In many instances – from controversies
over drug and vaccine safety, to the negotiation of appro-
priate treatment pathways – expert institutions and the
scientific perspectives that legitimize them have been cri-
tiqued by citizens' and patients organizations [48]. Such
critique, and forwarding of alternative perspectives, has
been based both on people's own lay knowledge and
'experiential expertise', and on the knowledge of experts
in alternative and complementary therapies. In many
developing country settings, the plurality of technical
knowledge and perspectives is even more pronounced, as
a multiplicity of local 'traditional', non-biomedical pre-
ventive and therapeutic forms interact with biomedicine
in new combinations and hybrids. Thus the argument that
shared language and understanding of scientific explana-
tions of nature has become the norm needs to be ques-
tioned, and qualified by asking who is in this community
of shared knowledge, and who is excluded?
See Table 3 for key points when considering science and
society.
Construction of social arrangements
Complex social arrangements are emerging in low-
income countries in the context of continually negotiated
power relationships and inequalities. Esping-Andersen
[49] suggests there are different welfare regimes that
reflect different understanding of the state's role and dif-
ferent expectations of stakeholders. MacIntosh and Roy
[50] argue these different expectations explain the path-
dependent nature of social policy. Stability of these
regimes and of the attitudes of actors within them has
made possible development of increasingly complex insti-
tutional arrangements and generation of a body of evi-
dence on how alternative arrangements influence
performance. Yet even in advanced market economies,
this common understanding may be coming under pres-
sure due to the emergence of new types of institutions, the
influence of new medical technologies, new technologies
for knowledge management, and the challenge to existing
social arrangements from expanded global competition.
The situation is fluid in low-income countries experienc-
ing rapid social change; the roles of government and other
regulatory agencies are evolving quickly. This is taking
place in the context of rapidly changing patterns of ine-
quality, where stakeholders are renegotiating their posi-
tion [51]. One of the paradoxes of the health sector and
other high trust social enterprises in circumstances of
strongly contested power relationships, is that in order for
institutions to function well they need high levels of social
legitimacy, that mostly imply universal rights and obliga-
tions. However, these are superimposed on competing
discourses around legitimate and illegitimate inequalities.
How can one construct a social consensus to underpin the
functioning of complex institutional arrangements in a
context of rapid change? How can one enable competition
and struggle while constructing high trust institutions?
How can one engender the kinds of trust necessary for the
functioning of a knowledge economy, while also preserv-
ing participation in decision-making that allow different
forms of knowledge and ideals concerning nature and
social institutions to coexist? These latter requirements
Table 2: Virtual versus grassroots realities – key points
1. Marked difference between theory and practice in health systems operation
2. Informal mechanisms are parallel to formal processes, and are not well understood
3. Analysis of opinion leader functioning is critical
4. Donor agencies influence health systems development, often to the exclusion of other stakeholders but may be non-inclusive
Table 3: Science and society – key points
1. Development of a scientific community is critical to consider
2. Perceptions (and explanations) of science varies in different societies
3. Alternative approaches to health require exploration
4. Inclusion and exclusion from the 'knowledge community' require analysisBMC Public Health 2007, 7:309 http://www.biomedcentral.com/1471-2458/7/309
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may indeed go together, since as recent work suggests, if
citizens are to find institutional arrangements and policy
processes trustworthy, they have to see in them a capacity
to take their concerns seriously [48]. These are critical
areas of inquiry for the context within which research and
evidence ought to influence policy and practice. See Table
4 for key points when considering construction of social
arrangements.
Approaches to the research-policy interface
In view of the dynamic context within which health deci-
sions are being taken (described above), an exploration of
the research to policy interface becomes more challenging
in the developing world. As a consequence, it is conceptu-
ally easier to disaggregate the critical aspects of this inter-
face. This section identifies three such areas that provide
entry points into the research to policy interface.
Recognizing policy as political and complex processes
The traditional model of policy making is a linear process
in which rational decisions are taken by those with
authority and responsibility for a particular policy area
[31]. In this highly-stylized view policy proceeds through
a set of stages from understanding the nature of the prob-
lem (agenda-setting), to exploring possible problem reso-
lution options, weighing up costs and benefits, making a
rational choice about best options (decision-making),
and finally implementation, possibly followed by evalua-
tion. 'Evidence' may be called upon at any or all of these
stages.
Others argue for a more complex view of policy develop-
ment and the relationship with knowledge [36]. Bowen
and Zwi [52] refer to "pathways to evidence-informed
policy and practice", describing a myriad of channels
through which evidence influences policy; Buse and col-
leagues [53] make a similar argument. Keeley and Scoones
[35] propose a framework for understanding policy proc-
esses concerning the environment, as the interaction of
competing interest groups; actors and networks; and pol-
icy narratives and discourse. Fairhead and Leach [32] con-
sider relationships between science and policy in
developing countries in similar terms. In these frame-
works, the process of gathering evidence for policy is
envisaged less as the result of a pure and rational quest for
what is technically correct – and more about the establish-
ment of 'facts' within particular networks. It is the influ-
ence of such networks and their stability in mainstream
institutions, nationally and internationally, that is central
to their ability to affect policy change.
Shifting the focus of empirical analysis to a process-based
view of policy involves recognition that policy-making
must be understood as a political process, as much as an
analytical or problem solving one. This means that over-
lapping and competing agendas exist, decisions are not
discrete and technical, and that facts and values are inter-
twined – all variables that characterize the process of deci-
sion making.
Policy-making is also complex because it takes place at
multiple levels – from international to local. Similarly,
implementation of these policies occurs at multiple levels
and involves discretion and negotiation at all levels. The
perceptions of different officials (both governmental and
non-governmental) at various tiers are critical to consider
[42]. National officials are often strongly influenced by
forward-looking policy debates, projections of future
developments, and international experiences. Sub-
national officials often tend to respond to local con-
straints and support local innovations, while being skep-
tical of the relevance of ideas from the top. There is a clear
need to understand how evidence influences decision
making at each of these levels and in addition how the lev-
els interact with each other. See Table 5 for key points
when considering policy as political and complex proc-
esses.
Engaging key stakeholders: decision-makers, providers, scientists, 
and communities
Four key actors are essential to consider when analyzing
health sector policy – the government, health providers,
Table 4: Construction of social arrangements – key points
1. Social arrangements continuously in flux
2. Inequalities in health, a central consideration, can be seen as legitimate or illegitimate
3. Social legitimacy of policy making is a critical area of enquiry
Table 5: Policy as political and complex processes – key points
1. Linear versus complex views of policy making processes
2. High level of influence of policy networks
3. Crucial to understand political dimensions of policy making process
4. Multiple tiers of policy making – from international to localBMC Public Health 2007, 7:309 http://www.biomedcentral.com/1471-2458/7/309
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scientists, and the community. Bound together through
principal-agent relationships and accountabilities, each
group has an important role in health research and policy.
A vital element for promoting the use of health research
for policy development needs greater attention – the
engagement of decision makers. There has been a growing
realization among both researchers and decision makers
that research can improve management decisions and the
performance of national health systems [3]. The interna-
tional development community is now supporting this
realization; an example is the Mexico Ministerial Summit
on Health Research, which took place in 2004 [54]. How-
ever, there is a lack of scientific knowledge on the mecha-
nisms to promote such engagement and their level of
success, especially in low-income countries. For example,
health policy forums, which have been used in many
developed countries, appear not to have been fully evalu-
ated in terms of their potential utility in low-income
countries.
Conduct of research or existence of evidence does not
guarantee input into the policy development process
unless decision makers are appropriately engaged. The
process of translation of research findings into pro-policy
information  is a critical and yet under-studied process.
Informal and formal mechanisms used for such transla-
tion and the types of people involved, especially in enti-
ties like health policy units, are particularly important to
consider. Further, 'demand driven research networks' that
respond to national decision maker questions by analyz-
ing and synthesizing available evidence into a user
friendly form need to be better explored in a developing
world setting. Models for such networks exist in the devel-
oped world – for example the Health Evidence Network of
WHO Europe [55] – and have the potential for applica-
tion in low-income countries.
Although global and national efforts have been made to
consult with decision makers, empirical work in this field is
lacking, especially in low-income countries. As a result,
there is a need to understand how decision makers view
research and what will stimulate them to promote health
systems research. Well-developed methodological inquiry
to document determinants of decisions, funding flows,
and catalysts for policy development are needed. The use
of standardized empirical approaches across multiple
countries may illuminate understanding of evidence or
knowledge valued in various countries, and how particu-
lar contexts affect policy development processes.
Scientific experts and decision makers can 'mutually con-
struct' policy, jointly negotiating questions to be answered
and types of knowledge to answer them. Scientists can
contribute to framing policy issues by defining what evi-
dence can be produced and its policy significance; deci-
sion makers can frame scientific enquiry by defining areas
of relevance and pertinent areas for investigation. This is
sometimes referred to as the co-production of science and
policy; thus policy and science are inextricably linked
[56]. Should scientists leave policy to policy-makers or
should they venture an opinion on policy based on their
scientific findings. Arguments have been presented on
keeping research findings and policy making separate
[57]; the alternative view, that researchers should be
unfettered to make policy suggestions, has also been
defended [58].
Scientists and decision makers are fundamentally differ-
ent on various dimensions [13,59]. Recognizing the cur-
rent schism between these two groups, it is instructive to
explore the definition of both policy and science. Policy
has been defined as, "a course of action or principle
adopted or proposed by a government, party, business, or
individual" [60]; science has been defined as "the state of
knowing: knowledge as distinguished from ignorance or
misunderstanding" [61]. These two definitions do not
appear to indicate a clash between science and policy; in
fact the two seem complementary. Science need not
merely inform policy, but policy-making can itself
become a science, and this might have significant implica-
tions. Who should these 'policy scientists' be? Is there a
need, as some suggest for a new profession of intermedi-
aries between decision makers and research scientists
[59]; or can scientists skilled in policy making, and deci-
sion makers skilled in public health science take on this
role?
The need for continuous exchange of ideas between scien-
tists and decision makers throughout the policy making
process has been suggested [62]. Given the importance of
communication for effective public health practice [63]
this continuous exchange is essential to effective public
health policy making. Effective ways of promoting and
sustaining such communication need development and
testing in low-income countries.
Health providers play a central role in policy implementa-
tion, and are often pivotal in the development of new pol-
icies. In some cases they share professional interests with
the scientific researchers, often sharing similar education
and values. In many cases, the stakeholder group most
neglected is the community – the beneficiaries of the
health system. Health policymaking is incomplete if the
focus is solely on government and providers; community
participation cannot be overlooked. The examination of
how decision makers and researchers in developing coun-
tries currently place the role of such approaches, or how
communities view the national policy making process, is a
research agenda. In particular, exploration of how com-BMC Public Health 2007, 7:309 http://www.biomedcentral.com/1471-2458/7/309
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munities affect local policy making and implementation,
but perhaps more importantly how these local decisions
affect national policy may prove particularly enlightening.
Further, how these local communities utilize research
conducted at local or national levels – and how formal
research perspectives articulate with community knowl-
edge and perspectives concerning health issues – warrant
empirical consideration. See Table 6 for key points when
considering the engagement of key stakeholders.
Enhancing accountability
Accountability refers to one group being responsible for
something or to another group, and being able to explain
their actions. Policy processes include some perspectives
at the expense of others. Much previous research suggests
perspectives of the poor and marginalized are often
excluded. The role of measuring and monitoring account-
ability  in policy proposals and policy implementation
warrants careful analysis. Information from low-income
countries is particularly scant on such health policy
accountability. A promising example comes from the
work on benchmarks of fairness for health care reform in
several developing countries [64,65]. Such assessment
using a broad interpretation of fairness for health sector
reform proposals allows a focused evaluation of account-
abilities.
The role of equity analysis in the research-policy interface
needs to be specifically documented; key equity criteria to
use in such an analysis have previously been articulated
[66]. This may include research on the response of the
health system to needs of the poor or specific vulnerable
groups. A better understanding of the role of civil society
organizations that represent the interests of the poor and
the sources of knowledge they use is also needed.
The human rights dimensions of health research for policy
cannot be ignored. How is this dimension incorporated
into health policy formation in low-income countries?
Health policies have an undoubted impact on the human
rights of particularly vulnerable populations as well as on
mainstream populations. Frameworks for the analysis of
health policies in terms of human rights ramifications are
available [67]. The use of such frameworks may prove an
illuminating means of carrying out such an analysis; this
may be of critical importance given an often stated focus
of health and development policies affecting the poor. See
Table 7 for key points when considering the enhancement
of accountability.
Frameworks and linkages
A discussion of the three entry points within the context
of the four developmental perspectives demonstrates the
disparate considerations required at the research-policy
interface in low-income countries. The complexity of
attempts to gain an understanding of this interface
becomes apparent. How can these disparate considera-
tions be brought together? A possible approach is pre-
sented in the proposed conceptual framework for
research-policy interface analysis in low-income countries
(Figure 1). Despite the apparent simplicity of the frame-
work each component within the framework is complex,
and is described in this paper. Some additional points are
made here to add clarity to the framework.
Three entry points to the research-policy interface are pre-
sented and these are labeled 'policy processes'; 'stake-
holder interests, values, and power'; and 'accountability'
(Figure 1). 'Policy processes' includes all the factors dis-
cussed in the section on recognizing policy as political
and complex processes. 'Stakeholder interests, values, and
power' includes the factors discussed in the section on
engaging key stakeholders (decision-makers, providers,
scientists, and communities). Stakeholders refer to "indi-
viduals or groups with a substantive interest in an issue,
including those with some role in making a decision or its
execution [53]." Stakeholders have "interests", but also
have "values" and "power". Values refer to "what we
Table 7: Enhancing accountability – key points
1. Perspectives of the poor and marginalized are often excluded from policy making
2. Benchmarks of fairness can be applied to health systems development plans
3. Equity analysis methods can be applied to enhance accountability
4. Frameworks can be utilized to analyze the human rights impacts of health policies
Table 6: Engaging key stakeholders – key points
1. Four key actors: government; providers; scientists; and the community
2. Government decision maker perspectives on evidence translation warrants evaluation
3. Methods of user-friendly packaging of evidence require testing
4. Fundamental differences exist between decision makers and scientists
5. Community perspectives on science and policy making require investigationBMC Public Health 2007, 7:309 http://www.biomedcentral.com/1471-2458/7/309
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believe in, what we hold dear about the way we live" and
these values "influence our behavior as persons, groups,
communities, cultures – perhaps as species [68]."
'Accountability' includes all the factors discussed in the
section on enhancing accountability and refers to respon-
sibilities governing relationships between stakeholders,
and their ability to explain their actions. These three entry
points are of course inter-related. They are placed within a
context provided by the four developmental perspectives
as discussed in the previous section. Context refers to "sys-
tematic factors – political, economical, social, or cultural,
both national and international – which may have an
effect on health policy [53]."
Each of the three entry points affects the research-policy
interface, represented by the box at the center of the
framework (Figure 1). The three entry points as well as the
interface itself are affected by the four developmental per-
spectives. As the entry points converge on the 'interface
box' and merge with one another it becomes evident that
many of the issues can be placed in more than just one of
the conceptual groupings. It remains illuminating how-
ever, to carry out such conceptual grouping in order to
increase clarity in examining the distinct types of influ-
ences on the research-policy interface. This may aid in
both retrospective and prospective analysis of the decision
making process.
Responding to gaps in knowledge on the research-policy 
interface
Understanding critical issues in the relationship between
research and policy, together with an appreciation of the
context is a prerequisite to further investigation of the
interface. An exploration of the interface based on the pro-
posed conceptual framework, can use a wide variety of
approaches; these are described below. This section on
theory forms the basis of empirical work to be conducted
by FHS country teams and aims to highlight important
methodological issues.
Potential study designs
A number of different types of designs can be used in
exploring the research-policy interface. These include:
policy focused approaches; research focused approaches;
and cross sectional approaches. Policy focused approaches
involve selection of a specific national (or local) policy
and retrospectively tracing the determinants of policy
development or its implementation. In particular, the
forms of knowledge, actors, networks, and interests
involved in policy development can be examined using
this approach. When considering policy development this
approach examines matters in terms of people, evidence,
and processes; such a design attempts to develop an
explanatory framework for the existence of a specific health
policy in the hope of learning if that framework can be
generalized to other instances. When policy implementa-
tion is the focus, exploration hones in on the process used
to implement a policy over a few years and documents the
role of research in its success (or failure) [15].
Research focused approaches are a much more challenging
and time consuming design. The approach prospectively
follows a body of evidence and seeks to track the impact
of the evidence on the development or refinement of pol-
icy at national or local level. The expectation of this design
is a body of relevant and well-developed research should
impact on policy at national level, and studying that proc-
ess will allow key determinants of such a flow to be mon-
itored and documented [69].
Finally, cross sectional approaches are the simplest design
and documents existing processes in the research-policy
interface. This approach helps to identify research priority
selection methods, mechanisms to translate research to
policy, and effects of policy demands on research agendas;
either policy or research is a starting point for inquiry [70].
Potential methodologies
A number of specific methods can be used to explore the
research to policy interface. They include: surveys; in-
depth or semi-structured interviews; focus group discus-
sions; document reviews; news/media analysis; and a vari-
ety of participatory methods using visual approaches such
as institutional mapping. Surveys can be used to seek spe-
cific information regarding the research-policy interface
based on a structured interview format. These can be
applied to individuals (most common) or institutions,
and usually involve closed-ended questions and can cover
a breadth of issues [15]. In-depth or semi-structured inter-
views offer a more open ended version to seek information
Proposed conceptual framework: The research-policy inter- face in low-income countries Figure 1
Proposed conceptual framework: The research-pol-
icy interface in low-income countries. 
DP = Developmental Perspective.BMC Public Health 2007, 7:309 http://www.biomedcentral.com/1471-2458/7/309
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from individuals usually focusing on a few areas. When
they are used in earlier phases to guide further explora-
tions or when they are targeted to specific individuals,
they are referred to as 'key informant' interviews [71]. Focus
group discussions offer a discussion format to identify com-
mon perspectives on key issues and are very useful to
either provide a broad coverage of issues or test out ideas
(such as potential interventions). Document reviews pro-
vide an opportunity for analysis of existing literature espe-
cially government reports, policy briefs, statements and
unpublished documents [70]. News and media analysis has
been used to understand how the media reports both
research and policy issues. This has also been used to
explore the 'public understanding of science'. Finally, a
range of methods drawing on the broader field of partici-
patory research and appraisal [72] involves engaging pol-
icymakers and researchers in reflection on the nature of
policy processes and the influences on them. Tools such as
the visual mapping of institutions and actor-networks,
timelines and event histories have also been usefully
incorporated into such processes [73].
Research involving decision makers warrants specific con-
sideration. First, since decision makers are very busy and
unlikely to give extended time, methodological options
are often limited. Second, the key to such exploration is to
understand decision maker attitudes and perspectives,
and therefore opportunities for them to provide such
views needs to be prioritized; interestingly, decision mak-
ers often find it refreshing and illuminating to reflect on
processes they may have taken for granted. Third, in view
of the above circumstances, a mix-methods approach is
often used involving both qualitative and quantitative
methods. Fourth, levels of analysis need to be defined (for
example a focus on national, state, or district level deci-
sion makers); this should not however preclude analysis
at multiple levels, tracking policy processes and actor-net-
works across these levels. Lastly, a decision maker needs to
be carefully defined (for example as an individual who
has  decision making authority or authority to allocate
funds). Illustrative guides to the types of decision makers
that need to be engaged at national and local levels are
listed in Table 8.
Application of theory to practice
Clear gaps in current literature are cross-sectional, multi-
country, collaborative studies ensuring comparability of
methods; this could potentially be a great step forward in
this field of inquiry. Six country teams within the FHS
research consortium are utilizing approaches summarized
in this paper to enhance knowledge on research-policy
interface strengthening. Research activities in one partner
country – Bangladesh – are described to elucidate how the
presented theory is being used in practice.
The FHS country team in Bangladesh has chosen to
explore the informal health care system in a rural area of
Bangladesh. This is an innovative area of work looking
outside the confines of formal health systems and is thus
in keeping with the consortium focus on innovations. The
proposed framework has been utilized to highlight key
areas requiring exploration. Each of the four developmen-
tal perspectives has contributed to the proposed research.
First, social institutional factors highlight the importance
Table 8: Types of decision makers at national and local level (illustrative only)
NATIONAL LOCAL
GOVERNMENT
Ministry of Health: Minister; Secretary; Director-General; Assistant 
Director General for Research
Heads of National Institutes: Health; Public Health; Statistical; 
Demographic; Medical Research
National Assembly/Parliament: Prime Minister or President; Head 
of Standing Committee on Health
Ministry of Finance and/or Planning: Minister; Secretary; Director-
General; Head of Health Sector
Ministry of Science and Technology: Minister; Secretary; Director-
General; Head of Health Affairs
Ministry of Education: Minister; Secretary; Director-General; Head of 
Health and Medical Section
GOVERNMENT
Health Administration: Head of Health Authority; Hospital Chief 
Executive; Head of District Health Center
Public Administration: Head of Local Government Authority; Head 
of Finance Department; Head of Education Department
PRIVATE FOR PROFIT
Head of hospital associations; Head of pharmaceuticals; Health insurance 
companies
PRIVATE FOR PROFIT
Head of companies with health schemes; Private health care providers
CIVIL SOCIETY
NGO/PVO Head/Chief of Party
CIVIL SOCIETY
Head of local NGO/PVO; Traditional and religious leaders; Union 
leaders; Community leaders
HEALTH CARE PROVIDERS
Head of medical, nursing, and other professional associations
HEALTH CARE PROVIDERS
Doctors; Nurses; Community Health Workers; Pharmacists; Traditional 
HealersBMC Public Health 2007, 7:309 http://www.biomedcentral.com/1471-2458/7/309
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of exploring rapidly changing complex rural health organ-
izations (by conducting institutional analysis); the inter-
face between formal and informal institutions; and the
expectations that stakeholders have of these institutions.
Second, considering differences in virtual versus grass-
roots realities highlights the importance of information
gathering from rural users of the informal health system;
increasing understanding of opinion leaders in rural set-
tings; and exploring donor agency perspectives on incor-
porating the informal health sector in health systems
development. Third, the interaction of science and society
is being explored in depth to determine population per-
ceptions of the science underpinning formal and informal
health care systems and the determinants of alternative
approaches to health. Lastly, the construction of social
arrangements is being explored in a rural setting – the
health seeking behavior of the poor is focused upon.
Considering the three entry points within the framework
allows focus on pertinent areas of investigation. Policy
processes are being examined with a special focus on the
local rural political landscape as well as influential deci-
sion-maker networks. Stakeholder interests, values, and
power are being explored through formal stakeholder
analyses – this analysis covers a wide spectrum of stake-
holders including the government (at multiple levels),
providers, researchers, and the community. Issues related
to accountability are being explored by focusing on the
perspectives of poor and marginalized beneficiaries.
Study designs and methods described in this section are
being utilized by the FHS Bangladesh country team –
while explorations are at an early stage, the framework has
provided a sound grounding for activities. As Bangladesh
and the other five FHS country teams begin to report their
findings it is envisioned that the conceptual framework
will be tested and further refined.
Conclusion
The rapidly evolving nature of the research to policy inter-
face within low-income country settings necessitates sub-
stantial use of novel approaches to respond to this
evolution. These approaches include: utilization of a con-
ceptual framework of the interface that highlights the
importance of particular entry points and appreciates
essential developmental perspectives; new methodologi-
cal techniques in analyzing the interface; choice of
research topics with significant scope for innovation; and
creative partnership formation to carry out the analysis.
Many sources of innovations currently influence health
systems. Some arise from importation of organizational
arrangements from other societies; policy leaders largely
introduce these. Others emerge as local adaptations to
local challenges. A third source is new technologies and
new organizational forms. These new technologies may
play a more dynamic role in rapidly changing societies
than in ones with well-established welfare regimes.
Analyses of current flow of innovations into the health
system are instructive to health systems development.
Many ideas for reform are transmitted through interna-
tional agencies. There is a need to explore how these agen-
cies perceive their role in knowledge transmission. There
is also need to carefully explore emerging local innova-
tions and how information about them is diffused; docu-
menting different understandings of the purpose of these
innovations and their performance is essential. Instances
where importation of ideas has led to successful national
innovations need examination. In particular, examples of
the market creating innovative organizational arrange-
ments require careful analysis.
Research conducted by Future Health Systems represent a
great opportunity to develop an empirical basis for under-
standing how decision makers perceive research, and
what value they ascribe to it in terms of their own decision
making in the health sector. Such projects can also illumi-
nate attractive research characteristics from a decision
maker perspective and thus suggest types of research these
decision makers are likely to commission. Empirical work
can allow a powerful qualitative comparison of similari-
ties and differences in the perspective of decision makers
across countries and issues. It may also help to define how
global programs can promote health research to decision
makers and what generic characteristics of research make
it useful for decision-making. Such empirical studies will
be innovative in low-income countries in focusing on
decision maker's perspective towards health research uti-
lizing standard methods and a cross-sectional, multi-
country approach. The developmental context incorpo-
rated into the entire endeavor can significantly enrich the
findings. A vision of health system development cogni-
zant of the myriad factors at the research-policy interface
can establish the basis for future health systems.
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